Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer

Publisher： Karger

E-ISSN： 1423-0232|90|3|127-135

ISSN： 0030-2414

Source： Oncology, Vol.90, Iss.3, 2016-02, pp. : 127-135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence of Cold-Induced Peripheral Neuropathy and Dose Modification of Adjuvant Oxaliplatin-Based Chemotherapy for Patients with Colorectal Cancer

By  

Oncology, Vol. 87, Iss. 3, 2014-07 ,pp. : 167-172

Karger

Access to resources Recommend Favorite

Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event

By  

Case Reports in Oncology, Vol. 6, Iss. 3, 2013-12 ,pp. : 609-615

Karger

Access to resources Recommend Favorite

PKC/MEK inhibitors suppress oxaliplatin‐induced neuropathy and potentiate the antitumor effects

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 1, 2015-07 ,pp. : 243-250

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients

By  

CANCER, Vol. 120, Iss. 23, 2014-12 ,pp. : 3691-3698

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combined Irinotecan, Oxaliplatin and 5-Fluorouracil in Patients with Advanced Colorectal Cancer

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 254-265

Karger

Access to resources Recommend Favorite